TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15799138

Group type: EXPERIMENTAL
Intervention: Bedtime diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12789956

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Kids' Power Toothbrush (D10) for 2 months
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Kids' Power Toothbrush (D10)
Number of subjects: 154
Study: 9583333

Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal (PI) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interpersonal style groups
Number of subjects: 0
Study: 7617806

Group type: EXPERIMENTAL
Intervention: Moclobemide (300‐600 mg daily)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Fluoxetine (20‐40 mg daily)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Moclobemide (600 mg daily after doubling dosage for non-responders)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Fluoxetine (40 mg daily)
Number of subjects: 99
Study: 2571689

Group type: EXPERIMENTAL
Intervention: Intracerebroventricular bethanechol chloride infusion
Number of subjects: 49
Study: 666936

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 60
Study: 31352178

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 30
Study: 29284427

Group type: EXPERIMENTAL
Intervention: DED patients
Number of subjects: 217
Study: 25706090

Group type: EXPERIMENTAL
Intervention: Prolonged exposure + exercise (PE+E)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Prolonged exposure (PE)
Number of subjects: 9
Study: 23571626

Group type: EXPERIMENTAL
Intervention: Automated outbound telephone messaging
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control pharmacies (no messaging)
Number of subjects: 192
Study: 21470363

Group type: EXPERIMENTAL
Intervention: Isokinetic assessment in supine lying with arm at 90° abduction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isokinetic assessment in supine lying with arm at 45° abduction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isokinetic assessment in seated position with arm in scapular plane
Number of subjects: 12
Study: 19030908

Group type: EXPERIMENTAL
Intervention: Fermented milk supplemented with calcium (f-milk + Ca)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopeptides (f-milk + Ca + ITF + CPP)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fermented milk (f-milk) without supplements
Number of subjects: 85
Study: 16601534

Group type: EXPERIMENTAL
Intervention: 12-week behavioral intervention guided by the Transtheoretical Model and motivational interviewing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 14623523

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg daily
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg daily
Number of subjects: 1276

Group type: EXPERIMENTAL
Intervention: Letrozole (neoadjuvant)
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Tamoxifen (neoadjuvant)
Number of subjects: 1276
Study: 11101198

Group type: EXPERIMENTAL
Intervention: 50 mg mibefradil per day
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 100 mg mibefradil per day
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 150 mg mibefradil per day
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (during run-in period)
Number of subjects: 114
Study: 8992903

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg IV 30 min before anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 1303408

Group type: EXPERIMENTAL
Intervention: Conventional management and 4 sessions of hyperbaric oxygen therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 30
Study: 4027121

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Promethazine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mebhydrolin
Number of subjects: 12
Study: 31392496

Group type: EXPERIMENTAL
Intervention: Primary internal fixation with unreamed interlocking nail
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Primary internal fixation with plate
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Primary internal fixation
Number of subjects: 29
Study: 29898848

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg bid or 2.5 mg bid if combined with antiplatelet therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC Group) including VKA therapy or antiplatelet therapy (single or dual)
Number of subjects: 0
Study: 27143498

Group type: EXPERIMENTAL
Intervention: Home-based alcohol prevention program (5 modules received by mail every 4 weeks over 5 months)
Number of subjects: 1349

Group type: COMPARATOR
Intervention: Control group (factsheet information brochure)
Number of subjects: 1349
Study: 23782517

Group type: EXPERIMENTAL
Intervention: Psychoeducational group (PEG) intervention
Number of subjects: 367

Group type: COMPARATOR
Intervention: Support group (SG) intervention
Number of subjects: 367
Study: 22744517

Group type: EXPERIMENTAL
Intervention: Autogenous bone grafts
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cages (titanium interbody implants)
Number of subjects: 55
Study: 20378644

Group type: EXPERIMENTAL
Intervention: Hemoglobin targets
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Baseline echocardiograms
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Systolic BP
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Baseline LVMI
Number of subjects: 596
Study: 18777992

Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Number of subjects: 408

Group type: COMPARATOR
Intervention: Nicotine gum
Number of subjects: 408
Study: 15545235

Group type: EXPERIMENTAL
Intervention: New personal protective eyewear
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Artificially aged personal protective eyewear
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no eyewear)
Number of subjects: 20
Study: 11744789

Group type: EXPERIMENTAL
Intervention: Troponin-I-based protocol
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 400
Study: 9431711

Group type: EXPERIMENTAL
Intervention: Topical 3% diclofenac in 2.5% hyaluronic acid gel
Number of subjects: 130

Group type: COMPARATOR
Intervention: Gel containing 2.5% hyaluronic acid alone
Number of subjects: 130
Study: 10129395

Group type: EXPERIMENTAL
Intervention: Expert opinion/group judgement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies (prospective cohort, case control, retrospective studies, cross-sectional, case studies)
Number of subjects: 0
Study: 3693756

Group type: EXPERIMENTAL
Intervention: Calorically defined exchange diet (EXCH)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Unmeasured diet avoiding refined sugars (UNMEAS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Low carbohydrate intake (less than 30%)
Number of subjects: 51
Study: 29111905

Group type: EXPERIMENTAL
Intervention: 100 mg/day CoQ10 supplements
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26801783

Group type: EXPERIMENTAL
Intervention: Gap measurement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Computer navigation
Number of subjects: 120
Study: 25980298

Group type: EXPERIMENTAL
Intervention: Rituximab in combination with methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 0
Study: 22817868

Group type: EXPERIMENTAL
Intervention: 8 mg of inhaled Salvinorin A
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 12 mg of inhaled Salvinorin A
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0 mg of inhaled Salvinorin A (control)
Number of subjects: 10
Study: 20113923

Group type: EXPERIMENTAL
Intervention: It's Your Game: Keep it Real (IYG) intervention
Number of subjects: 907

Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 907
Study: 18832343

Group type: EXPERIMENTAL
Intervention: Tolterodine (4 mg/d)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Darifenacin (15 mg/d)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 16898488

Group type: EXPERIMENTAL
Intervention: Fetuin A concentration in children with nephrotic syndrome (NS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Fetuin A concentration in control group (K)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fetuin A concentration in children with chronic renal failure (CRF)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Correlations of fetuin A in children with NS
Number of subjects: 53

Group type: COMPARATOR
Intervention: Correlations of fetuin A in groups K and CRF
Number of subjects: 53
Study: 12810503

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) treatment (50 U per axilla)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Quality of life parameters and satisfaction after BTX‐A treatments
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Safety profile of BTX‐A
Number of subjects: 207
Study: 11014752

Group type: EXPERIMENTAL
Intervention: Low workload condition
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Medium workload condition
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: High workload condition
Number of subjects: 126
Study: 8780660

Group type: EXPERIMENTAL
Intervention: 1-unit donation (206 +/- 10 mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2-unit donation (414 +/- 21 mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham donation
Number of subjects: 30
Study: 1621675

Group type: EXPERIMENTAL
Intervention: Low-protein diets
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Restricted phosphorus diets
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control diet (not specified)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Overall diet groups
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Blood pressure control (not specified)
Number of subjects: 96
Study: 6715694

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention (enhancement of empathy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate plus cognitive-behavioral intervention
Number of subjects: 0
Study: 31647843

Group type: EXPERIMENTAL
Intervention: 1.25mg intravitreal ziv‐aflibercept (IVZ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2mg intravitreal ziv‐aflibercept (IVZ)
Number of subjects: 20
Study: 27670875

Group type: EXPERIMENTAL
Intervention: Traditional Chinese spinal orthopedic manipulation (TCSOM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pinaverium Bromide (PBD)
Number of subjects: 80
Study: 27839534

Group type: EXPERIMENTAL
Intervention: Specially qualified family companions (experimental intervention)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional care companions (control intervention)
Number of subjects: 63
Study: 23918282

Group type: EXPERIMENTAL
Intervention: Balloon treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 40
Study: 23163251

Group type: EXPERIMENTAL
Intervention: Communication training programme (17-hour programme across 8 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 10
Study: 18767928

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg every 6 months)
Number of subjects: 1189

Group type: COMPARATOR
Intervention: Alendronate (70 mg weekly)
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 1189

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Denosumab and Alendronate
Number of subjects: 1189
Study: 17485150

Group type: EXPERIMENTAL
Intervention: recombinant subunit gp350 Epstein-Barr virus vaccine
Number of subjects: 148
Study: 15478752

Group type: EXPERIMENTAL
Intervention: Short feedback-processing time condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long feedback-processing time condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information-integration category learning
Number of subjects: 0
Study: 11566144

Group type: EXPERIMENTAL
Intervention: Opioid blockade with naltrexone (single oral dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (no opioid blockade)
Number of subjects: 0
Study: 9861567

Group type: EXPERIMENTAL
Intervention: Amikacin single daily dosage (20 mg/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Amikacin twice daily dosage (20 mg/kg)
Number of subjects: 23
Study: 7946862

Group type: EXPERIMENTAL
Intervention: Midazolam (0.06 mg kg‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol (2.2 mg kg‐1 h‐1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No sedative drug (group ND)
Number of subjects: 45
Study: 3364222

Group type: EXPERIMENTAL
Intervention: Self-monitoring (SM)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (CR)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Restrained control (RC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Unrestrained control (UC)
Number of subjects: 76
Study: 29446174

Group type: EXPERIMENTAL
Intervention: Family-based treatment for bulimia nervosa (FBT-BN)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for adolescents (CBT-A)
Number of subjects: 110

Group type: COMPARATOR
Intervention: FBT-BN
Number of subjects: 110

Group type: COMPARATOR
Intervention: CBT-A
Number of subjects: 110
Study: 29894613

Group type: EXPERIMENTAL
Intervention: Iron supplementation in women with moderate preeclampsia (Io group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Iron supplementation in women with severe preeclampsia (II group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (I) - 26 nulliparous women undergoing planned Cesarean section
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (IQ) - 22 healthy non-pregnant women
Number of subjects: 62
Study: 23529870

Group type: EXPERIMENTAL
Intervention: 12-week preventive intervention (n=78)
Number of subjects: 139

Group type: COMPARATOR
Intervention: self‐study control (n=61)
Number of subjects: 139
Study: 23885960

Group type: EXPERIMENTAL
Intervention: PROSPER intervention (family-based in sixth grade and school-based in seventh grade)
Number of subjects: 11000

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 11000
Study: 20838357

Group type: COMPARATOR
Intervention: MGP
Number of subjects: 48

Group type: COMPARATOR
Intervention: IVB (1.25 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: IVB followed by MGP
Number of subjects: 48
Study: 18551283

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acute stress exposure
Number of subjects: 38
Study: 17087779

Group type: EXPERIMENTAL
Intervention: 400 microg FA
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 5 mg FA
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: betaine 100 mg kg(‐1) day(‐1)
Number of subjects: 128

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 128

Group type: COMPARATOR
Intervention: placebo (for betaine group)
Number of subjects: 128
Study: 12818978

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 130

Group type: COMPARATOR
Intervention: Ondansetron 8 mg
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg plus Ondansetron 4 mg
Number of subjects: 130
Study: 15231978

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 10195517

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 0.5 mg/kg p.o. 1 hour before surgery
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 1.0 mg/kg p.o. 1 hour before surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 57
Study: 7662220

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2323832

Group type: EXPERIMENTAL
Intervention: Photographic method for assessing changes in eye redness
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High doses of birch pollen
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lower doses of birch pollen (about half the effective dose)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Questionnaires measuring sensory irritation (dryness)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Photographic measurement of eye redness
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Relation between eye redness and eye irritation
Number of subjects: 17
Study: 6985760

Group type: EXPERIMENTAL
Intervention: Intermittent sequential pneumatic compression (six chambers) at pressures of 35, 30, and 20 mm Hg for 12 seconds
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonsequential device (one chamber) inflated at 35 mm Hg for 12 seconds
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sequential compression device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Small-dose subcutaneous heparin
Number of subjects: 10
Study: 31536116

Group type: EXPERIMENTAL
Intervention: AAR + counseling
Number of subjects: 327
Study: 28627002

Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk assessment
Number of subjects: 103
Study: 25822543

Group type: EXPERIMENTAL
Intervention: Kiva
Number of subjects: 300

Group type: COMPARATOR
Intervention: Balloon Kyphoplasty (BK)
Number of subjects: 300
Study: 23670326

Group type: EXPERIMENTAL
Intervention: Inhaled steroids
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral steroids
Number of subjects: 32
Study: 21851905

Group type: EXPERIMENTAL
Intervention: Endothelial progenitor cell capturing stents (ECS)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 1300
Study: 19194783

Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Estrogen and Raloxifene
Number of subjects: 150
Study: 17955843

Group type: EXPERIMENTAL
Intervention: Surgery performed by experienced surgeon (group 1; n=41 eyes)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Surgery performed by two residents (group 2; n=40 eyes)
Number of subjects: 76
Study: 15540912

Group type: EXPERIMENTAL
Intervention: Ceftriaxone, 1 g given twice a day until occurrence of meningitis or at least 5 days after trauma
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no antibiotic medication)
Number of subjects: 109
Study: 11552768

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (Cere)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 9041304

Group type: EXPERIMENTAL
Intervention: 1500 mg/kg RSVIG
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 8174569

Group type: EXPERIMENTAL
Intervention: Once-daily dosage of 60 mg isosorbide-5-mononitrate
Number of subjects: 37

Group type: COMPARATOR
Intervention: Twice-daily dosage of 60 mg isosorbide-5-mononitrate
Number of subjects: 37
Study: 3148071

Group type: EXPERIMENTAL
Intervention: Oral betaine, 3 g b.i.d
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31488084

Group type: EXPERIMENTAL
Intervention: Proactive telephone toxicity management
Number of subjects: 500

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 500
Study: 28654365

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus ovarian function suppression (OFS)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Exemestane plus OFS
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus OFS (TEXT)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Exemestane plus OFS (TEXT)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: OFS
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Protocol-assigned endocrine therapy
Number of subjects: 582
Study: 25474533

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 3746

Group type: EXPERIMENTAL
Intervention: Statin use in the preceding week
Number of subjects: 3746

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 3746
Study: 23939291

Group type: EXPERIMENTAL
Intervention: Silicone hydrogel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rigid gas‐permeable
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (NCCA)
Number of subjects: 20
Study: 21751994

Group type: EXPERIMENTAL
Intervention: Expressive writing task
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control writing task
Number of subjects: 88
Study: 19486959

Group type: EXPERIMENTAL
Intervention: Self-management program
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 152
Study: 17598141

Group type: EXPERIMENTAL
Intervention: Self-management therapy (n = 51)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Active-control therapy (n = 50)
Number of subjects: 101
Study: 15349113

Group type: EXPERIMENTAL
Intervention: Internet-based curriculum in critical appraisal skills (including clinical and methodologic articles, listserve discussion, critiques)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (only clinical articles)
Number of subjects: 55